Identifying patient-reported anxiety and depression in older adults with cancer.
Reena Jayani(Vanderbilt University Medical Center), Daneng Li(City Of Hope National Medical Center), Marianna Koczywas(City Of Hope National Medical Center), William Dale(City of Hope), Vincent Chung(City of Hope), Enrique Soto‐Pérez‐de‐Celis(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Mina S. Sedrak(University of California, Los Angeles), Supriya G. Mohile(University of Rochester Medical Center), Can‐Lan Sun(University of Minnesota), Sumanta K. Pal(City of Hope), Arti Hurria(Unknown), Mihaela Cristea(City Of Hope National Medical Center), Marwan Fakih(City of Hope), Kemeberly Charles(City of Hope), Vani Katheria(City of Hope), Elsa Roberts(City of Hope), Leana Cabrera Chien(City of Hope), Jeanine Moreno(City of Hope), Joseph Chao(Amgen (United States))
Cited by 0
Related Papers
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
|The Lancet Oncology|2018|2.5k
Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study
|Journal of Clinical Oncology|2011|1.8k
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
|The Lancet Oncology|2017|1.8k
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
|Journal of Clinical Oncology|2015|1k
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
|CA A Cancer Journal for Clinicians|2015|737